Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
QGQiagen N.V. logo

Qiagen N.V. (QGEN)

New York Stock Exchange · Currency in USD
$50.39 ▲ +0.17 (+0.34%)
At close: Oct 23, 4:00 PM ET. Market closed.
$50.39 ▲ +0.00 (+0.00%)
After hours: Oct 23, 5:36 PM ET

Summary

Previous Close
$50.22
Open
$50.38
Day's Range
$50.33 – $50.45
52 Week Range
$32.53 – $57.82
Volume
7,144,093
Avg. Volume
3,313,143
Market Cap
$10.38B
Beta (5Y Monthly)
0.61
PE Ratio (TTM)
25.84
EPS (TTM)
$1.98
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
$0.70 (1.39%)
Ex-Dividend Date
Jul 7, 2026
1y Target Est
$44.01

Profile: Qiagen N.V.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Full-time employees
5,500
CEO
Jon Pratt
Website
qiagen.com

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate $0.63 · Revenue est. $538.61M
DateEst.Actual
Aug 5, 2026$0.60$0.62Beat
May 6, 2026$0.54$0.54Miss
Feb 4, 2026$0.61$0.62Beat
Nov 4, 2025$0.61$0.64Beat
Aug 5, 2025$0.60$0.60Beat
May 7, 2025$0.50$0.55Beat

Analyst view

Consensus price target
$44.01 ▼ -12.7%
Range $38.60 – $52.00
Rating: Hold
Buy 43% · Hold 57% · Sell 0%

Get free alerts on QGEN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.